How is the Novo Nordisk - ADR today?

The Novo Nordisk - ADR today is trading in the green, up by 2.94% at 71.50.

How has Novo Nordisk - ADR performed historically?

The Novo Nordisk - ADR is currently trading up 2.94% on an intraday basis in the past week the index rose 6.16%. The index has been down -19.86% in the past quarter and fell -46.16% in the past year. You can view this in the overview section.

What is Novo Nordisk - ADR Annual Revenue?

Novo Nordisk - ADR Annual Revenue rose 25.03%, in the last year to $290,403 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Novo Nordisk - ADR Annual Net Profit?

Novo Nordisk - ADR Annual Net Profit rose 20.68% in the last year to $100,988 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Novo Nordisk - ADR Price to Earning Ratio?

Novo Nordisk - ADR Price to Earning Ratio is 19.96, higher than its sector PE ratio of 4.35.

What is Novo Nordisk - ADR Stock Price?

Novo Nordisk - ADR Stock Price fell 46.16% and underperformed its sector by 101.63% in the past year.

What is Novo Nordisk - ADR Quarterly Revenue?

Novo Nordisk - ADR Quarterly Revenue rose 19.49% YoY to $78,087 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Novo Nordisk - ADR Quarterly Net profit?

Novo Nordisk - ADR Quarterly Net profit rose 14.28% YoY to $29,034 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Novo Nordisk - ADR Debt to Equity Ratio?

Novo Nordisk - ADR Debt to Equity Ratio of 0.72 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Novo Nordisk - ADR Return on Equity(ROE)?

Novo Nordisk - ADR Return on Equity(ROE) for the last financial year was 80.78%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

What is Novo Nordisk - ADR Mutual Fund Holding?

Novo Nordisk - ADR Mutual Fund Holding decreased by 0% in the last quarter to 2.93.

What is Novo Nordisk - ADR Interest Coverage Ratio?

Novo Nordisk - ADR Interest Coverage Ratio is 78.56, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Novo Nordisk - ADR Institutional Holding?

Novo Nordisk - ADR Institutional Holding decreased by 0.31% in the last quarter to 7.37.

Novo Nordisk - ADR XNYS: NVO

Novo Nordisk - ADR Live Share Price Today, Share Analysis and Chart

Name: Novo Nordisk - ADR: Is Infosys Ltd. worth buying?
Item: Novo Nordisk - ADR
Rating: 1.898805625
Author: Trendlyne DVM scores

Expensive Performer

about

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, inject...

71.50 2.04 (2.94%)

51.74% Fall from 52W High

11.2M XNYS Volume

XNYS 30 May, 2025 5:30 PM (EDT)

Medium Financial Strength

38.9 / 100

Expensive Valuation

28.7 / 100

Technically Neutral

45.5 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 27%

11 analysts

Novo Nordisk - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Novo Nordisk - ADR Live Share Price Today, Share Analysis and Chart

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, inject...

51.74% Fall from 52W High

Novo Nordisk - ADR Live Price Chart

Novo Nordisk - ADR FAQ

How is Novo Nordisk - ADR today?

Novo Nordisk - ADR today is trading in the green, and is up by 2.94% at 71.50.

How has Novo Nordisk - ADR performed historically?

Novo Nordisk - ADR is currently trading up 2.94% on an intraday basis. In the past week the stock rose 6.16%. stock has been down -19.86% in the past quarter and fell -46.16% in the past year. You can view this in the overview section.